INDUCTION OF T-CELL IMMUNE RESPONSE IN CHRONIC HCV-INFECTED PATIENTS WITH UNDERLYING DENDRITIC CELL IMMUNOTHERAPY

Código QR

INDUCTION OF T-CELL IMMUNE RESPONSE IN CHRONIC HCV-INFECTED PATIENTS WITH UNDERLYING DENDRITIC CELL IMMUNOTHERAPY

A key role of T cells in viral elimination and absence of strong T cell responses in patients with chronic hepatitis C virus (HCV) infection presumes that activation of antigen-specific T cells may be a promising approach to enhance treatment efficacy. Given the central role of dendritic cells (...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	E. R. Chernykh, E. A. Oleynik, O. Yu. Leplina, M. A. Tikhonova, Yu. D. Kurochkina, N. M. Starostina, А. А. Ostanin
Formato:	article
Lenguaje:	RU
Publicado:	SPb RAACI 2017
Materias:	chronic hcv infection antigen-specific t cell response core antigen ns3 antigen immunotherapy dendritic cells Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/8264f161056a4ce5bd4969565088d3b4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Induction of HCV-specific cell response in vitro by dendritic cells generated with interferon-α
por: E. R. Chernykh, et al.
Publicado: (2019)

Dendritic cells in the pathogenesis of viral hepatitis C
por: Elena Removna Chernykh, et al.
Publicado: (2019)

The Advantages and Challenges of Anticancer Dendritic Cell Vaccines and NK Cells in Adoptive Cell Immunotherapy
por: Elena V. Abakushina, et al.
Publicado: (2021)

EFFECT OF ANTIGEN-PRIMED DENDRITIC CELL-BASED IMMUNOTHERAPY ON ANTITUMOR CELLULAR IMMUNE RESPONSE IN PATIENTS WITH COLORECTAL CANCER
por: V. V. Kurilin, et al.
Publicado: (2021)

ADAPTIVE T-CELL RESPONSE IN PATHOGENESIS OF HEPATITIS C INFECTION
por: E. A. Oleynik, et al.
Publicado: (2016)

New insights to the functional role of the T cell-Antigen Presenting Cell immunological synapse
por: FAROUDI,MUSTAPHA, et al.
Publicado: (2002)

<italic toggle="yes">Staphylococcus aureus</italic> Impairs the Function of and Kills Human Dendritic Cells via the LukAB Toxin
por: Evelien T. M. Berends, et al.
Publicado: (2019)

Comparison of four methods of colon cancer cell lysates preparation for ex vivo maturation of dendritic cells
por: Mohammad Roufarshbaf, et al.
Publicado: (2022)

Maturation of dendritic cells in vitro and immunological enhancement of mice in vivo by pachyman- and/or OVA-encapsulated poly(D,L-lactic acid) nanospheres
por: Zheng SS, et al.
Publicado: (2018)

INTERDEPENDENCE BETWEEN THE PHENOTYPE OF DENDRITIC CELLS AND AMOUNTS OF BLOOD PROINFLAMMATORY MONOCYTES IN PATIENTS WITH KIDNEY CANCER
por: A. A. Savchenko, et al.
Publicado: (2019)

The normal chain length distribution of the O antigen is required for the interaction of Shigella flexneri 2a with polarized Caco-2 cells
por: Hoare,Anilei, et al.
Publicado: (2012)

Spinoculation and retronectin highly enhance the gene transduction efficiency of Mucin-1-specific chimeric antigen receptor (CAR) in human primary T cells
por: Alireza Rajabzadeh, et al.
Publicado: (2021)

Cell Therapy for Colorectal Cancer: The Promise of Chimeric Antigen Receptor (CAR)-T Cells
por: Cristina Aparicio, et al.
Publicado: (2021)

How Can We Engineer CAR T Cells to Overcome Resistance?
por: Glover M, et al.
Publicado: (2021)

Complement C3-dependent uptake of targeted liposomes into human macrophages, B cells, dendritic cells, neutrophils, and MDSCs
por: Francian A, et al.
Publicado: (2017)

Immunohistochemical Characterization of Human Synovial Bursa Cells by Light and Transmission Electron Microscopy: Where do These Cells Come From?
por: Hirschmann,Michael Tobias, et al.
Publicado: (2007)

Pushing Past the Blockade: Advancements in T Cell-Based Cancer Immunotherapies
por: Jessica Waibl Polania, et al.
Publicado: (2021)

Secretory Microneme Proteins Induce T-Cell Recall Responses in Mice Chronically Infected with <named-content content-type="genus-species">Toxoplasma gondii</named-content>
por: Iti Saraav, et al.
Publicado: (2019)

SEMI–MATURE DENDRITIC CELLS AS A POTENTIAL BASIS FOR THE INDUCTION OF ANTI–TUMOR RESPONSE IN PATIENTS WITH MALIGNANT GLIOMAS
por: O. Yu. Leplina, et al.
Publicado: (2014)

Enhanced anti-tumor immunotherapy by silica-coated magnetic nanoparticles conjugated with ovalbumin
por: Lee SJ, et al.
Publicado: (2019)

PHENOTYPIC PECULIARITIES OF DENDRITIС CELLS DIFFERENTIATED FROM BLOOD MONOCYTES IN PATIENTS WITH KIDNEY CANCER
por: A. A. Savchenko, et al.
Publicado: (2018)

Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy
por: Yan-Ruide Li, et al.
Publicado: (2021)

SHORT OVERVIEW OF CLINICAL TRIALS WITH CURRENT IMMUNOTHERAPEUTIC TOOLS FOR CANCER TREATMENT
por: T. S. Nepomnyashchikh, et al.
Publicado: (2017)

Polymer nanoparticles for cross-presentation of exogenous antigens and enhanced cytotoxic T-lymphocyte immune response
por: Song C, et al.
Publicado: (2016)

PEGylated and CD47-conjugated nanoellipsoidal artificial antigen-presenting cells minimize phagocytosis and augment anti-tumor T-cell responses
por: Song S, et al.
Publicado: (2019)

Epigenetic Priming of Bladder Cancer Cells With Decitabine Increases Cytotoxicity of Human EGFR and CD44v6 CAR Engineered T-Cells
por: Camilla M. Grunewald, et al.
Publicado: (2021)

Study on the Relationship Between the Expression of B Cell Mature Antigen and the Classification, Stage, and Prognostic Factors of Multiple Myeloma
por: Tiantian Ma, et al.
Publicado: (2021)

Chitosan-Poly(Acrylic Acid) Nanoparticles Loaded with R848 and MnCl2 Inhibit Melanoma via Regulating Macrophage Polarization and Dendritic Cell Maturation
por: Liu X, et al.
Publicado: (2021)

EFFECT OF DEXAMETHASONE ON INTERFERON-α-INDUCED DIFFERENTIATION OF MONOCYTES TO DENDRITIC CELLS
por: Yu. D. Kurochkina, et al.
Publicado: (2016)

Higher serum homocysteine level and frequency of hyperhomocysteinemia in carcinoembryonic antigen-positive or squamous cell carcinoma-antigen-positive oral leukoplakia patients
por: Yu-Hsueh Wu, et al.
Publicado: (2021)

Genetically Modified T Cells for Esophageal Cancer Therapy: A Promising Clinical Application
por: Yu-Ge Zhu, et al.
Publicado: (2021)

CELLULAR IMMUNOTHERAPY: A MODERN APPROACH TO TREATMENT OF ONCOLOGICAL DISEASES
por: Yu. N. Lezhnin, et al.
Publicado: (2018)

Surface-associated antigen induces permeabilization of primary mouse B-cells and lysosome exocytosis facilitating antigen uptake and presentation to T-cells
por: Fernando Y Maeda, et al.
Publicado: (2021)

Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors
por: Christopher Sloas, et al.
Publicado: (2021)

CORRECTION OF INTERFERON-α-INDUCED DENDRITIC CELL DYSFUNCTIONS IN IMMUNOCOMPROMISED PATIENTS
por: O. Yu. Leplina, et al.
Publicado: (2012)

Dendritic Cells and Cancer Immunotherapy: The Adjuvant Effect
por: Sara Nava, et al.
Publicado: (2021)

IFNα-INDUCED DENDRITIC CELLS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND THEIR SENSITIVITY TO DEXAMETHASONE
por: E. R. Chernykh, et al.
Publicado: (2017)

IN VITRO CELLULAR INTERACTIONS DURING IMMUNE RESPONSE TO T CELLINDEPENDENT TYPE 2 ANTIGENS
por: M. V. Gavrilova, et al.
Publicado: (2014)

PHENOTYPE AND FUNCTIONS OF DENDRITIC CELLS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS
por: O. Yu. Leplina, et al.
Publicado: (2014)

Occurrence of Dengue Virus Infection with Multiple Serotypes at Central Karnataka, India
por: VinodKumar CS, et al.
Publicado: (2021)